Articles dans des revues avec comité de lecture (64)
  1. 1. Lavis, P., Bondue, B., & Cardozo, A. K. (2024). The Dual Role of Chemerin in Lung Diseases. Cells, 13(2), 171. doi:10.3390/cells13020171
  2. 2. Vandenbempt, V., Eski, S. E., Brahma, M. K., Li, A., Negueruela Escudero, J., Bruggeman, Y., Demine, S., Xiao, P., Cardozo, A. K., Baeyens, N., Martelotto, L., Singh, S. P., Mariño, E., Gysemans, C., & Gurzov, E. N. (2023). HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes. iScience, 27(1), 108694. doi:10.1016/j.isci.2023.108694
  3. 3. Lavis, P., Pingitore, J., Doumont, G., Garabet, A., Van Simaeys, G., Lacroix, S., Passon, N., Van Heymbeek, C., De Maeseneire, C., Allard, J., Collin, A., Huaux, F., Decaestecker, C., Salmon, I., Goldman, S., Cardozo, A. K., & Bondue, B. (2023). Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis. Respiratory research, 24(1), 254. doi:10.1186/s12931-023-02556-6
  4. 4. Takiishi, T., Xiao, P., Franchimont, M., Gilglioni, E. H., Arroba, E., Gurzov, E. N., Bertrand, M., & Cardozo, A. K. (2023). Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation. Molecular metabolism, 69, 101681. doi:10.1016/j.molmet.2023.101681
  5. 5. Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.941663
  6. 6. Brahma, M. K., Xiao, P., Popa, M., Negueruela Escudero, J., Vandenbempt, V., Demine, S., Cardozo, A. K., & Gurzov, E. N. (2022). Nova1 or Bim Deficiency in Pancreatic β-Cells Does Not Alter Multiple Low-Dose Streptozotocin-Induced Diabetes and Diet-Induced Obesity in Mice. Nutrients, 14(18). doi:10.3390/nu14183866
  7. 7. Xiao, P., Takiishi, T., Moretti Violato, N., Licata, G., Dotta, F., Sebastiani, G., MARSELLI, L., Singh, S. P., Sze, M., Van Loo, G., Dejardin, E., Gurzov, E. N., & Cardozo, A. K. (2022). NF-kappaB-inducing kinase (NIK) is activated in pancreatic beta-cells but does not contribute to the development of diabetes. Cell death & disease, 13(5). doi:10.1038/s41419-022-04931-5
  8. 8. Fløyel, T., Meyerovich, K., Prause, M. M., Kaur, S., Frørup, C., Mortensen, H. B., Nielsen, L. B., Pociot, F. M., Cardozo, A. K., & Størling, J. (2021). Skap2, a candidate gene for type 1 diabetes, regulates b-cell apoptosis and glycemic control in newly diagnosed patients. Diabetes (New York, N.Y.), 70(2), 464-476. doi:10.2337/db20-0092
  9. 9. Tiezzi, M., Morra, S., Seminerio, J., Van Muylem, A., Godefroid, A., Law-Weng-Sam, N., Van Praet, A., Corbiere, V., Orte Cano, C., Karimi, S., Del Marmol, V., Bondue, B., Benjelloun, M., Lavis, P., Mascart, F., Van De Borne, P., & Cardozo, A. K. (2021). SP-D and CC-16 Pneumoproteins' Kinetics and Their Predictive Role During SARS-CoV-2 Infection. Frontiers in Medicine, 8, 761299. doi:10.3389/fmed.2021.761299
  10. 10. Meyerovich, K., Ortis, F., & Cardozo, A. K. (2018). The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes. Journal of molecular endocrinology, 61(2), F1-F6. doi:10.1530/JME-16-0183
  11. 11. Nardelli, T. R., Vanzela, E. C., Benedicto, K. K., Brozzi, F., Fujita, A., Cardozo, A. K., Eizirik, D. L., Boschero, A. C., & Ortis, F. (2018). Prolactin protects against cytokine-induced beta-cell death by NFκB and JNK inhibition. Journal of molecular endocrinology, 61(1), 25-36. doi:10.1530/JME-16-0257
  12. 12. Lambelet, M., Terra, L. F., Fukaya, M., Meyerovich, K., Labriola, L. L., Cardozo, A. K., & Allagnat, F. (2018). Dysfunctional autophagy following exposure to pro-inflammatory cytokines contributes to pancreatic β-cell apoptosis. Cell death and disease, 9(2), 96. doi:10.1038/s41419-017-0121-5
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>